Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
03/2003
03/13/2003US20030049732 Apoptosis related polynucleotides, polypeptides, and antibodies
03/13/2003US20030049725 Anti-TNF antibodies, compositions, methods and uses
03/13/2003US20030049723 MAGE-A3 peptides presented by HLA class II molecules
03/13/2003US20030049699 Polypeptide for use in the treatment of cell proliferation disorders
03/13/2003US20030049672 Modulation of protein binding; obtain sample containing polypeptides, incubate with modulator, detect adjustment in protein activity
03/13/2003US20030049662 Oligonucleotides for use in the treatment of wounds, cardiovascular, cell proliferative and developmental disorders
03/13/2003US20030049643 G protein-coupled receptors for use in the treatment of cardiovascular, nervous system, angina pectoris, inflamatory bowel, allergies and gastrointestinal disorders
03/13/2003US20030049617 Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
03/13/2003US20030049302 Anticancer agent in intravagina device
03/13/2003US20030049281 Topical emulsion; quaternary ammonium salt emulsifier
03/13/2003US20030049266 Induce immunology response usin gpolynucleotide
03/13/2003US20030049262 Methods for identification, diagnosis, and treatment of breast cancer
03/13/2003US20030049257 Anticancer agents; administering interleukin polypeptide
03/13/2003US20030049252 Controlling immunology response; autoimmune disease, antiallergens
03/13/2003US20030049239 Antitumor agents, anticancer agent
03/13/2003US20030049227 Antitumor, anticarcinogenic agents; using fusion protein
03/13/2003US20030049203 Targeted nucleic acid constructs and uses related thereto
03/13/2003DE3890874C2 Rekombinante Viren Recombinant viruses
03/13/2003CA2471735A1 Desensitizers
03/13/2003CA2459937A1 Ncam binding compounds
03/13/2003CA2459822A1 Treatment of chronic myelogenous leukemia, resistant or intolerant to sti571, involving homoharringtonine alone or combined with other agents
03/13/2003CA2459796A1 Homing peptides
03/13/2003CA2459584A1 Compositions and use thereof in the treatment of cancer
03/13/2003CA2459583A1 Compositions and methods of treatment of cancer
03/13/2003CA2459413A1 Methods for sterilizing preparations containing albumin
03/13/2003CA2459348A1 Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions
03/13/2003CA2459161A1 Phosphodiesterase activity and regulation of phosphodiesterase 1-b-mediated signaling in brain
03/13/2003CA2459077A1 Diagnosis of carcinomas
03/13/2003CA2458963A1 Increased solubility flavanolignan preparations
03/13/2003CA2458915A1 Nucleic acid and corresponding protein entitled 205p1b5 useful in treatment and detection of cancer
03/13/2003CA2458876A1 Methods of maturing plasmacytoid dendritic cells using immune response modifier molecules
03/13/2003CA2458780A1 Targeted nucleic acid constructs and uses related thereto
03/13/2003CA2458682A1 Nanoparticles comprising biologically active tnf which is immobilised on the same
03/13/2003CA2458670A1 Bv8 nucleic acids and polypeptides with mitogenic activity
03/13/2003CA2458538A1 Antigen mimotopes and vaccine against cancerous diseases
03/13/2003CA2458459A1 Anti-cancer combinations
03/13/2003CA2458399A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
03/13/2003CA2457922A1 Novel pyrazole analogs acting on cannabinoid receptors
03/13/2003CA2457541A1 Methods for the identification of polypeptide antigens associated with disorders involving aberrant cell proliferation and compositions useful for the treatment of such disorders
03/13/2003CA2457526A1 Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
03/13/2003CA2455126A1 Antineoplastic combinations
03/12/2003EP1291437A1 New assay for inhibitors of translocases
03/12/2003EP1291430A1 Ceramide kinase and dna encoding the same
03/12/2003EP1291424A1 Gasc1 gene
03/12/2003EP1291423A1 Polyfunctional base sequence and artificial gene containing the same
03/12/2003EP1291422A2 Human nucleic acid from ovarian tumor tissue
03/12/2003EP1291362A1 A complex between folic acid and polysaccharides, its preparation method and a pharmaceutical composition comprising said complex as active component
03/12/2003EP1291345A1 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
03/12/2003EP1291340A1 Phytosphingosine derivatives with antitumor activity
03/12/2003EP1291022A1 Methods of using lanreotide, a somatostatin analogue
03/12/2003EP1291019A1 Biologically active agents and drugs
03/12/2003EP1291015A1 Dosage forms having prolonged active ingredient release
03/12/2003EP1290205A2 Duplexed parvovirus vectors
03/12/2003EP1290204A1 Antisense modulation of c/ebp alpha expression
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290188A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290182A1 Sphingosine kinase and uses thereof
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290171A2 Compositions and methods for the therapy and diagnosis of lung cancer
03/12/2003EP1290170A2 Binding agents: chimeric ligand/receptor proteins
03/12/2003EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
03/12/2003EP1290167A1 Human kcnq5 potassium channel, methods and compositions thereof
03/12/2003EP1290162A2 Induction of apoptosis and cell growth inhibition by protein 4.33
03/12/2003EP1290161A1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi
03/12/2003EP1290152A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/12/2003EP1290148A2 AMINOACYL tRNA SYNTHETASES
03/12/2003EP1290140A1 Alpha (2) macroglobulin receptors as a heat shock protein receptor and uses thereof
03/12/2003EP1290139A2 METHODS FOR ASSAYING GENE IMPRINTING AND METHYLATED CpG ISLANDS
03/12/2003EP1290033A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
03/12/2003EP1290029A2 Compositions comprising net-4 modulators and their use for treating neoplastic disease
03/12/2003EP1290017A2 Compositions and methods for delivery of a molecule into a cell
03/12/2003EP1290012A2 2-amino-3-hydroxy-4-tert-leucyl-amino-5-phenyl-pentanoic acid amide derivatives
03/12/2003EP1290011A1 Melphalan derivatives and their use as cancer chemotherapeutic drugs
03/12/2003EP1290010A1 Pyridine-2-yl-aminoalkyl carbonyl glycyl-$g(b)-alanine and derivatives thereof
03/12/2003EP1290006A1 Combinatorial production of nucleotide and nucleoside (xitp)analogues
03/12/2003EP1290005A2 Vegf-modulated genes and methods employing them
03/12/2003EP1289999A1 Antitumoral analogs of et-743
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289992A1 New crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compound
03/12/2003EP1289990A1 Tetracyclic diketopierazine compounds as pdev inhibitors
03/12/2003EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists
03/12/2003EP1289977A2 Triterpenoid derivatives and their use as antiproliferative agents
03/12/2003EP1289976A1 Novel paclitaxel derivatives for the treatment of cancer
03/12/2003EP1289972A1 Serine protease inhibitors
03/12/2003EP1289961A1 Fluoroalkoxy-substituted benzamide dichloropyridinyl n-oxide pde4 inhibitor
03/12/2003EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
03/12/2003EP1289959A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289950A1 Serine protease inhibitors
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289939A1 Phenylglycine derivatives
03/12/2003EP1289923A2 Epithelial cell cancer drug
03/12/2003EP1289916A2 Purification of xanthophylls from marigold extracts that contain high levels of chlorophylls
03/12/2003EP1289571A2 Prochelators of radiometal labeled molecules
03/12/2003EP1289570A1 Liposomal encapsulation of chelated actinium-225 and uses thereof
03/12/2003EP1289568A2 Combination product for carrying out a cytotoxic treatment in a mammal
03/12/2003EP1289566A1 Ubiquitin promoter in vectors for gene therapy in respiratory tract
03/12/2003EP1289565A2 Compounds for targeting endothelial cells
1 ... 1592 1593 1594 1595 1596 1597 1598 1599 1600 1601 1602 1603 1604 1605 1606 1607 1608 1609 1610 1611 1612 ... 2211